Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies
Authors
Keywords
-
Journal
CNS SPECTRUMS
Volume 20, Issue 02, Pages 140-147
Publisher
Cambridge University Press (CUP)
Online
2014-06-23
DOI
10.1017/s1092852914000285
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Antony Loebel et al. AMERICAN JOURNAL OF PSYCHIATRY
- Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Antony Loebel et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo
- (2013) Stephen M. Stahl et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study
- (2013) Henry A. Nasrallah et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Effects of lurasidone in behavioral models of depression. Role of the 5-HT7 receptor subtype
- (2013) Lindsay N. Cates et al. NEUROPHARMACOLOGY
- Efficacy and safety of lurasidone 80mg/day and 160mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial
- (2013) Antony Loebel et al. SCHIZOPHRENIA RESEARCH
- Efficacy and safety of ziprasidone in the treatment of first-episode psychosis
- (2012) Tong Zhao et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Long-term safety and tolerability of lurasidone in schizophrenia
- (2012) Leslie Citrome et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
- (2012) Masaaki Ogasa et al. PSYCHOPHARMACOLOGY
- Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
- (2011) Herbert Y. Meltzer et al. AMERICAN JOURNAL OF PSYCHIATRY
- Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia
- (2011) Susana Majadas et al. COMPREHENSIVE PSYCHIATRY
- Review: Suicide and schizophrenia: a systematic review of rates and risk factors
- (2010) Kahyee Hor et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Lurasidone in the Treatment of Acute Schizophrenia
- (2009) Mitsutaka Nakamura et al. JOURNAL OF CLINICAL PSYCHIATRY
- Compelling or irrelevant? Using number needed to treat can help decide
- (2008) L. Citrome ACTA PSYCHIATRICA SCANDINAVICA
- Psychiatric Comorbidities and Schizophrenia
- (2008) P. F. Buckley et al. SCHIZOPHRENIA BULLETIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started